This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Vertex nets $488.4mm through follow-on public offering
Vertex Pharmaceuticals (developing small-molecule therapeutics for cancer, neurology, immune, inflammatory, viral, and respiratory diseases) has netted $488.4mm through the follow-on public offering of 13mm common shares (including the overallotment) at $38.50 apiece.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?